AS15 | CAS#102616-62-6 | Inhibitor

MedKoo Cat#: 463085 | Name: AS15

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AS15 is a novel covalent nanomolar inhibitor of protein disulfide isomerase (PDI).

Chemical Structure

AS15

CAS#102616-62-6

Theoretical Analysis

MedKoo Cat#: 463085

Name: AS15

CAS#: 102616-62-6

Chemical Formula: C20H23NO6

Exact Mass: 373.1525

Molecular Weight: 373.41

Elemental Analysis: C, 64.33; H, 6.21; N, 3.75; O, 25.71

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

AS15; AS 15; AS-15;

IUPAC/Chemical Name

6-((3,4-dimethoxyphenyl)(morpholino)methyl)benzo[d][1,3]dioxol-5-ol

InChi Key

POUGOEFZYGQTHG-UHFFFAOYSA-N

InChi Code

InChI=1S/C20H23NO6/c1-23-16-4-3-13(9-17(16)24-2)20(21-5-7-25-8-6-21)14-10-18-19(11-15(14)22)27-12-26-18/h3-4,9-11,20,22H,5-8,12H2,1-2H3

SMILES Code

OC1=C(C(N2CCOCC2)C3=CC(OC)=C(OC)C=C3)C=C(OCO4)C4=C1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 373.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Shergalis A, Xue D, Gharbia FZ, Driks H, Shrestha B, Tanweer A, Cromer K, Ljungman M, Neamati N. Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines. J Med Chem. 2020 Sep 24;63(18):10263-10286. doi: 10.1021/acs.jmedchem.0c00728. Epub 2020 Sep 11. PMID: 32830969. 2: Rosenbaum P, Artaud C, Bay S, Ganneau C, Campone M, Delaloge S, Gourmelon C, Loirat D, Medioni J, Pein F, Sablin MP, Tredan O, Varga A, Leclerc C. The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients. Cancer Immunol Immunother. 2020 May;69(5):703-716. doi: 10.1007/s00262-020-02503-0. Epub 2020 Feb 7. PMID: 32034426. 3: Kaida T, Yukawa C, Higashi S, Minami K, Miyata K. Presbyopia Correction Using Multifocal Soft Contact Lenses in Patients With Monofocal Intraocular Lenses. Eye Contact Lens. 2020 Jul;46(4):234-237. doi: 10.1097/ICL.0000000000000662. PMID: 31517737. 4: Demissie ZA, Brown WG, Loewen MC. A Universally Primed-Polymerase Chain Reaction (UP-PCR) Marker to Discriminate Clonostachys rosea ACM941 from Related Strains. J Fungi (Basel). 2019 May 14;5(2):39. doi: 10.3390/jof5020039. PMID: 31091661; PMCID: PMC6617100. 5: Guo J, Zhou A, Sun X, Sha W, Ai K, Pan G, Zhou C, Zhou H, Cong H, He S. Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice. Front Immunol. 2019 Mar 29;10:592. doi: 10.3389/fimmu.2019.00592. PMID: 30984177; PMCID: PMC6449433. 6: Rioux CR, Clapper ML, Cooper HS, Michaud J, St Amant N, Koohsari H, Workman L, Kaunga E, Hensley H, Pilorget A, Gerard C. Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models. PLoS One. 2019 Jan 25;14(1):e0210261. doi: 10.1371/journal.pone.0210261. PMID: 30682058; PMCID: PMC6347180. 7: McQuade JL, Homsi J, Torres-Cabala CA, Bassett R, Popuri RM, James ML, Vence LM, Hwu WJ. A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma. BMC Cancer. 2018 Dec 19;18(1):1274. doi: 10.1186/s12885-018-5193-9. PMID: 30567529; PMCID: PMC6300080. 8: Mannaa M, Kim KD. Effect of Temperature and Relative Humidity on Growth of Aspergillus and Penicillium spp. and Biocontrol Activity of Pseudomonas protegens AS15 against Aflatoxigenic Aspergillus flavus in Stored Rice Grains. Mycobiology. 2018 Sep 6;46(3):287-295. doi: 10.1080/12298093.2018.1505247. PMID: 30294490; PMCID: PMC6171444. 9: Mannaa M, Kim KD. Biocontrol Activity of Volatile-Producing Bacillus megaterium and Pseudomonas protegens Against Aspergillus and Penicillium spp. Predominant in Stored Rice Grains: Study II. Mycobiology. 2018 Mar 27;46(1):52-63. doi: 10.1080/12298093.2018.1454015. PMID: 29998033; PMCID: PMC6037079. 10: Dreno B, Thompson JF, Smithers BM, Santinami M, Jouary T, Gutzmer R, Levchenko E, Rutkowski P, Grob JJ, Korovin S, Drucis K, Grange F, Machet L, Hersey P, Krajsova I, Testori A, Conry R, Guillot B, Kruit WHJ, Demidov L, Thompson JA, Bondarenko I, Jaroszek J, Puig S, Cinat G, Hauschild A, Goeman JJ, van Houwelingen HC, Ulloa-Montoya F, Callegaro A, Dizier B, Spiessens B, Debois M, Brichard VG, Louahed J, Therasse P, Debruyne C, Kirkwood JM. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2018 Jul;19(7):916-929. doi: 10.1016/S1470-2045(18)30254-7. Epub 2018 Jun 13. PMID: 29908991. 11: Jeong JJ, Moon HJ, Pathiraja D, Park B, Choi IG, Kim KD. Draft Genome Sequences of Bacillus megaterium KU143, Microbacterium testaceum KU313, and Pseudomonas protegens AS15, Isolated from Stored Rice Grains. Genome Announc. 2018 May 31;6(22):e00468-18. doi: 10.1128/genomeA.00468-18. PMID: 29853508; PMCID: PMC5981034. 12: Grob JJ, Mortier L, D'Hondt L, Grange F, Baurain JF, Dréno B, Lebbe C, Robert C, Dompmartin A, Neyns B, Gillet M, Louahed J, Jarnjak S, Lehmann FF. Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature. ESMO Open. 2017 Nov 14;2(5):e000203. doi: 10.1136/esmoopen-2017-000203. PMID: 29177094; PMCID: PMC5687540. 13: Mannaa M, Oh JY, Kim KD. Biocontrol Activity of Volatile-Producing Bacillus megaterium and Pseudomonas protegens against Aspergillus flavus and Aflatoxin Production on Stored Rice Grains. Mycobiology. 2017 Sep;45(3):213-219. doi: 10.5941/MYCO.2017.45.3.213. Epub 2017 Sep 30. PMID: 29138628; PMCID: PMC5673519. 14: Zhang FG, Yan HF, Pan YJ, Zhao W. [Determination of fluorine-ion in human urine by ion chromatography method]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2017 Aug 20;35(8):622-624. Chinese. doi: 10.3760/cma.j.issn.1001-9391.2017.08.019. PMID: 29081138. 15: Delannois F, Planty C, Giordano G, Destexhe E, Stanislaus D, Da Silva FT, Stegmann JU, Thacker K, Reynaud L, Garçon N, Segal L. Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo- fetal and post-natal developmental toxicity studies in rats and rabbits. Reprod Toxicol. 2018 Jan;75:110-120. doi: 10.1016/j.reprotox.2017.09.006. Epub 2017 Sep 23. PMID: 28951173. 16: Tarro L, Aceves-Martins M, Papell-Garcia I, Arola L, Giralt M, Llauradó E, Solà R. A Youth-Led, Social Marketing Intervention Run by Adolescents to Encourage Healthy Lifestyles among Younger School Peers (EYTO-Kids Project): A Protocol for Pilot Cluster Randomized Controlled Trial (Spain). Int J Environ Res Public Health. 2017 Aug 17;14(8):923. doi: 10.3390/ijerph14080923. PMID: 32962313; PMCID: PMC5580625. 17: Chander S, Pandey RK, Penta A, Choudhary BS, Sharma M, Malik R, Prajapati VK, Murugesan S. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase. Comb Chem High Throughput Screen. 2017;20(8):734-746. doi: 10.2174/1386207320666170615104703. PMID: 28641512. 18: Higgins M, Curigliano G, Dieras V, Kuemmel S, Kunz G, Fasching PA, Campone M, Bachelot T, Krivorotko P, Chan S, Ferro A, Schwartzberg L, Gillet M, De Sousa Alves PM, Wascotte V, Lehmann FF, Goss P. Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study. Breast Cancer Res Treat. 2017 Apr;162(3):479-488. doi: 10.1007/s10549-017-4130-y. Epub 2017 Feb 7. PMID: 28176175; PMCID: PMC5332485. 19: Gutzmer R, Rivoltini L, Levchenko E, Testori A, Utikal J, Ascierto PA, Demidov L, Grob JJ, Ridolfi R, Schadendorf D, Queirolo P, Santoro A, Loquai C, Dreno B, Hauschild A, Schultz E, Lesimple TP, Vanhoutte N, Salaun B, Gillet M, Jarnjak S, De Sousa Alves PM, Louahed J, Brichard VG, Lehmann FF. Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study. ESMO Open. 2016 Aug 8;1(4):e000068. doi: 10.1136/esmoopen-2016-000068. PMID: 27843625; PMCID: PMC5070281. 20: Pujol JL, De Pas T, Rittmeyer A, Vallières E, Kubisa B, Levchenko E, Wiesemann S, Masters GA, Shen R, Tjulandin SA, Hofmann HS, Vanhoutte N, Salaun B, Debois M, Jarnjak S, De Sousa Alves PM, Louahed J, Brichard VG, Lehmann FF. Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study. J Thorac Oncol. 2016 Dec;11(12):2208-2217. doi: 10.1016/j.jtho.2016.08.120. Epub 2016 Aug 17. PMID: 27544054.